Nov 10 2020

Killing HER2 Softly with Drugs: Novel Therapies for Advanced HER2-Positive Breast Cancer with Brain Metastases – Pharmacy Resident Seminar November 10, 2020

November 10, 2020

12:30 PM - 1:20 PM

Location

Live Webinar

Address

IL 60612

Cost

Free

Please join us for our next Pharmacy Resident Seminar Presentation on Tuesday, November 10, 2020, via Live Webinar, presented by UIC College of Pharmacy PGY-1 Pharmacy Practice Resident, Sarvnaz Sadrameli, PharmD.

 

Type of Activity: Knowledge                                                                                                                             Target Audience: Pharmacists

Time: Tuesday, November 10, 2020,  12:30 pm - 1:20 pm

Fees: There is no charge for attending this activity

Location: Live Webinar

Webex Meeting Information: 
Meeting link: https://uichicago.webex.com/uichicago/onstage/g.php?MTID=e40eef610a496b4f2ca35395bc3ec9167
Meeting number: 120 371 9859
Password: 4U7pCXDJMp5
Or
Join by phone: +1-415-655-0001 United States Toll (Chicago)

Learning Objectives :

At the completion of this activity, the participant will be able to:

  • Review the prevalence, prognostic factors, and intrinsic subtypes of breast cancer based on their gene expression
  • Outline the treatment approach and clinical considerations for HER2-positive metastatic breast cancer
  • Explain the pharmacological properties of the novel agents for the treatment of HER2-positive advanced breast cancer with brain metastases
  • Discuss place in therapy of the novel agents for the treatment of HER2-positive advanced breast cancer with brain metastases

Disclosure: The speakers, planning committee members, and reviewers who contributed to this activity have no relevant financial conflicts of interest to disclose.

Contact

April Quarles

Date posted

Oct 27, 2020

Date updated

Nov 6, 2020

Speakers

Pharmacy Continuing Education Statement: The University of Illinois at Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been assigned ACPE Universal Activity Number 0016-0000-20-062-L01-P, for 1.0 contact hours (0.1 CEUs). Attendance at the entire knowledge-based activity, completion of the evaluation, and submission of NABP eProfile ID and MMDD are prerequisites for receiving continuing pharmacy education credit(s). All ACPE credit awarded to participants must be uploaded to CPE Monitor ™ within 30 days of the activity date, so pharmacists are required to provide their e-Profile ID and date of birth (MMDD) at the time of the activity. Please contact aquarl2@uic.edu if you do not see the activity information listed within 30 days.  For more information and to set up your e-Profile visit: www.MyCPEmonitor.net.